The Center for Global Health Policy’s “Science Speaks” blog examines how the “U.S. travel bans on people involved in sex work and people who have used illegal drugs … kept many of the people at highest risk from coming to the [XIX International AIDS Conference (AIDS 2012)]” in Washington, D.C., last month. “The result, observers said afterward, was a larger conference with fewer sex workers than had brought their first-hand experiences and concerns to Vienna and Mexico City,” according to the blog. Carlos Laudari, senior technical adviser for HIV AIDS prevention at Pathfinder, “and others said those in absentia were not the only ones disempowered; the loss of sex worker and drug user input on how to realize the goals of treatment as prevention, on barriers to funding, testing, health care access, and for that matter, on the difference between sex work and sex trafficking — commonly, and erroneously equated — weakened the dialogue and the action they were intended to inform,” the blog writes and quotes several other advocates (Barton, 8/8).
“Methadone treatment is proving to be the most efficient way to wean people in Bangladesh from addiction to buprenorphine, a pharmaceutical drug, and health experts say it should be expanded to reach thousands more drug users to prevent the spread of HIV,” IRIN reports. The news service notes that “illegal use of pharmaceutical substances, mostly buprenorphine, is on the rise” in the country. “Buprenorphine was intended to be used to wean injecting drug users, also known as people who inject drugs (PWID), from narcotics like heroin, but has itself become a substance of addiction, with users injecting a liquid form of it,” the news service notes, adding, “Methadone, a pain reliever, suppresses withdrawal symptoms and blocks craving.”
Russia Should Abandon ‘Zero-Tolerance’ Approach To Drug Use And Implement Proven Prevention Strategies
Why have effective, “simple tools such as Medication Assisted Therapy (methadone, buprenorphine) and clean needle-exchange services” — methods that are “very effective in decreasing drug abuse and reducing risk of infection with HIV, hepatitis C and other diseases” â€“ “had so little impact on the policies and programs of the Russian Federation?” Bertrand Audoin, executive director of the International AIDS Society, and Chris Beyrer, a professor at the Johns Hopkins Bloomberg School of Public Health, write in this New York Times opinion piece. With an “estimated number of injecting drug users [at] 1.8 million, and the estimated number of opiate users exceed[ing] 1.6 million,” and more than one million people living with HIV, “Russia now accounts for two thirds of the Eastern Europe and Central Asian HIV epidemic, the fastest growing in the world,” they write.
In this post in the State Department’s “DipNote” blog, Alyce Ahn, a foreign affairs officer in the State Department’s Bureau of International Narcotics and Law Enforcement Affairs (INL) Office of Anticrime Programs, writes about the U.S. delegation’s participation last week in the 55th session of the Commission on Narcotic Drugs (CND). She outlines the delegation’s work at the conference, concluding, “We’re already beginning to see operational results from the CND. One country noted that, in response to a resolution, it plans to look into using a life-saving drug that can help prevent deaths from overdose. For its part, the United States looks forward to working with other states, as well as [the U.N. Office on Drugs and Crime (UNODC)], in various joint projects and regional counter-narcotics initiatives addressed in the resolutions” (3/19).
“The savage cuts to Greece’s health service budget have led to a sharp rise in HIV/AIDS and malaria in the beleaguered nation, said a leading aid organization on Thursday,” the Guardian’s “News Blog” reports. “The incidence of HIV/AIDS among intravenous drug users in central Athens soared by 1,250 percent in the first 10 months of 2011 compared with the same period the previous year, according to” Reveka Papadopoulos, “the head of Medecins Sans Frontieres [MSF] Greece, while malaria is becoming endemic in the south for the first time since … the 1970s,” the blog notes.
Inter Press Service examines how Mexico’s government and non-governmental organizations are working to stem the spread of HIV among people who use injection drugs. “According to a project financed by the Global Fund to Fight AIDS, Tuberculosis and Malaria since 2011, the prevalence of HIV/AIDS in Mexico is 5.77 percent among intravenous drug users … compared to 0.24 to 0.3 percent in the general population aged 15 to 49,” IPS writes, noting HIV prevalence among drug users is highest in “northern Mexico, one of the areas in the country hit hardest by drug trafficking.” The news service adds “[t]here are 28 syringe exchange programs in this country of 112 million people, insufficient to serve the entire population of intravenous drug users.” IPS discusses funding shortfalls for syringe exchange programs, legal hurdles to obtaining clean injection equipment, and how the government aims to continue receiving Global Fund money through 2013 (Godoy, 10/11).
“The Kenyan government will begin distributing free syringes and needles to more than 50,000 [injection] drug users (IDUs) across the country in the next month,” PlusNews reports, adding, “Policy-makers and experts said the decision was reached following concerns over the spread of HIV and other blood-borne illnesses through injection drug use.” “[Injection] drug use is responsible for close to four percent of national HIV infections and 17 percent of new infections in Coast Province annually, according to government statistics,” according to the news service. “The government aims to distribute some eight million needles and syringes to drug users countrywide once the program is rolled out and will also encourage HIV testing, provide antiretroviral drugs, condoms, and medication for tuberculosis, the most commonly found co-infection with HIV” the news service writes (6/7).
“About 200 million people around the world use illegal drugs every year, and that may be taking a toll on health and death rates in various countries, says a report released Thursday in the Lancet,” the Los Angeles Times’ “Booster Shots” blog reports. According to the blog, “[t]he study, part of a series the journal is doing on addiction, offers a plethora of information about [the] use of opioids, amphetamines, cocaine and marijuana worldwide” (Stein, 1/5).
“New HIV cases and AIDS deaths are both going steadily down in British Columbia, according to data released last week,” the New York Times reports. Julio Montaner, director of the British Columbia Centre for Excellence in HIV/AIDS, said, “We’re particularly pleased to see that our treatment-as-prevention strategy has taken off big-time,” the newspaper notes, adding that the strategy, which aggressively identifies and treats people with HIV, “lowers by 96 percent the chances that they will infect others.” The New York Times writes, “Montaner said he is frustrated that rich countries will not donate enough money to roll out the strategy in poor countries with huge HIV epidemics” (McNeil, 1/2).
African Leaders Should 'Take Action' To Implement Human-Rights Based Laws, Policies To Enhance HIV Response
Noting the release of a report (.pdf) from the Global Commission on HIV and the Law showing that “punitive laws are standing in the way of effective AIDS responses,” Festus Mogae, former president of Botswana, and Stephen Lewis, co-director and co-founder of AIDS-Free World, both members of the commission, write in a health-e opinion piece, “We cannot hope for an HIV-free generation when we have laws that marginalize and punish those most vulnerable to the disease.” They state that certain laws and customs in Africa “undermine the ability of women to protect themselves” and marginalize sex workers and men who have sex with men (MSM).